Medication Use in Multiple Sclerosis: A Population-Based Comparison With the General Danish Population.

ABSTRACT:

Objective

To investigate the overall use of prescription medications among individuals with multiple sclerosis compared to the general population, with a focus on treatments beyond disease-modifying therapies.

Methods

We conducted a nationwide, registry-based study in Denmark. All residents with a diagnosis of multiple sclerosis aged 20-80 years and alive on January 1, 2023, were included and followed for 1 year. Each patient was matched with 10 individuals from the general population based on age, sex, and residence. Prescription data were obtained from the Danish National Prescription Registry and categorized using the Anatomical Therapeutic Chemical classification. Relative risks of medication use were calculated.

Results

A total of 14,491 individuals with multiple

SUBMITTER: Windfeld-Mathiasen J 

PROVIDER: S-EPMC12623830 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature